Magnolol Alleviates Pulmonary Fibrosis Inchronic Obstructive Pulmonary Disease by Targeting Transient Receptor Potential Vanilloid 4-Ankyrin Repeat Domain

Investigators studied the effect of magnolol on alleviating fibrosis in COPD based on transient receptor potential vanilloid 4 (TRPV4), and to further analyze its mechanism of action on TRPV4.